NovaBay Pharmaceuticals Inc (NBY)

Currency in USD
0.6175
+0.0127(+2.10%)
Closed·
NBY Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
NBY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.53830.6200
52 wk Range
0.44001.0099
Key Statistics
Prev. Close
0.6048
Open
0.583
Day's Range
0.5383-0.62
52 wk Range
0.44-1.0099
Volume
212.92K
Average Volume (3m)
36.13K
1-Year Change
14.78%
Book Value / Share
0.73
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NBY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

NovaBay Pharmaceuticals Inc Company Profile

NovaBay Pharmaceuticals, Inc. does not have significant operations. Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Employees
14

Compare NBY to Peers and Sector

Metrics to compare
NBY
Peers
Sector
Relationship
P/E Ratio
−0.4x−5.0x−0.5x
PEG Ratio
0.000.290.00
Price/Book
0.8x1.6x2.6x
Price / LTM Sales
0.4x1.6x3.3x
Upside (Analyst Target)
37.7%189.8%40.1%
Fair Value Upside
Unlock10.8%5.1%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-0.34 / 0.01
Revenue / Forecast
-- / 5.73M
EPS Revisions
Last 90 days

NBY Income Statement

People Also Watch

21.81
SRPT
+7.44%
38.31
EXEL
-0.42%
5.56
REPL
+3.93%
4.860
NDRA
+9.46%
105.270
VRNA
0.00%

FAQ

What Stock Exchange Does NovaBay Pharmaceuticals Trade On?

NovaBay Pharmaceuticals is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for NovaBay Pharmaceuticals?

The stock symbol for NovaBay Pharmaceuticals is "NBY."

What Is the NovaBay Pharmaceuticals Market Cap?

As of today, NovaBay Pharmaceuticals market cap is 3.60M.

What Is NovaBay Pharmaceuticals's Earnings Per Share (TTM)?

The NovaBay Pharmaceuticals EPS (TTM) is 0.41.

From a Technical Analysis Perspective, Is NBY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has NovaBay Pharmaceuticals Stock Split?

NovaBay Pharmaceuticals has split 3 times.

How Many Employees Does NovaBay Pharmaceuticals Have?

NovaBay Pharmaceuticals has 14 employees.

What is the current trading status of NovaBay Pharmaceuticals (NBY)?

As of 17 Aug 2025, NovaBay Pharmaceuticals (NBY) is trading at a price of 0.62, with a previous close of 0.60. The stock has fluctuated within a day range of 0.54 to 0.62, while its 52-week range spans from 0.44 to 1.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.